| | | | | | | |
 | CSL LIMITED | -0.74% | 1.26% | 7.03% | 14.66% | 8.17% | 98 391 |
 | BIOGEN INC. | -0.73% | 0.52% | 8.41% | 51.23% | -0.88% | 43 452 |
 | SAMSUNG BIOLOGICS CO.,LTD. | -0.38% | 1.03% | -4.38% | -6.88% | 24.80% | 42 866 |
 | WUXI BIOLOGICS (CAYMAN) INC. | 6.47% | 3.49% | -25.73% | -22.02% | 3.13% | 23 990 |
 | BIOMARIN PHARMACEUTICAL INC. | 5.78% | 5.51% | -9.79% | 23.33% | -13.82% | 17 524 |
 | UCB | 2.08% | -0.72% | 12.15% | 1.45% | -6.99% | 16 779 |
 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. | 1.63% | -0.39% | -17.81% | -14.67% | -12.73% | 16 311 |
 | BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. | -0.02% | -0.31% | -25.56% | -24.84% | 105.20% | 12 067 |
 | APELLIS PHARMACEUTICALS, INC. | 0.74% | 1.14% | 70.10% | 106.72% | 161.16% | 10 244 |
 | CELLTRION HEALTHCARE CO., LTD. | 0.00% | 4.07% | 32.24% | 30.77% | -10.09% | 9 468 |
 | AIM VACCINE CO., LTD. | 3.43% | 16.89% | 115.13% | --.--% | --.--% | 7 912 |
 | GRIFOLS, S.A. | 6.50% | 1.81% | 7.24% | -38.71% | -59.24% | 7 479 |
 | INNOVENT BIOLOGICS, INC. | 1.65% | -1.99% | 10.45% | 52.26% | -22.43% | 7 251 |
 | WALVAX BIOTECHNOLOGY CO., LTD. | 1.49% | 0.48% | -27.30% | -37.64% | -30.68% | 6 608 |
 | SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. | 0.15% | -3.21% | 4.73% | 19.00% | -20.29% | 6 321 |
| | | | | | | |
| Moyenne | 1.87% | 1.97% | 10.46% | 11.05% | 8.95% | |
| Moyenne pondérée par Capi. | 0.93% | 1.58% | 4.90% | 12.81% | 10.12% | |